by vesalius | May 26, 2022 | Events
EuroPCR 2022 was a very successful event for Vesalius. In parallel to presenting during the Innovators’ Day, Vesalius solution was published in EuroIntervention, the Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions...
by vesalius | May 13, 2022 | Events
Dr Peter Skarsgard, Vesalius President and Chief Scientific Officer, will be presenting Vesalius TMVr solution during the Innovators Day at EuroPCR in Paris on May 19th, 2022. We believe mitral valve repair for simple or complex degenerative mitral regurgitation,...
by vesalius | Feb 3, 2022 | Events
During the Access to Innovation 2022 event organized by Lifesciences BC on February 16 and 17, our Chief Operating Officer Vincent Ledoux will be speaking on a panel relating to using IP to scale companies. This conference brings together leaders from across academia,...
by vesalius | Nov 27, 2021 | Events
Vesalius team celebrated today 5 years of next generation engineering and advanced biomedical innovations. Advancing medicine and simplifying the treatment for Mitral Regurgitation is and will always be our priority. ...
by vesalius | Nov 25, 2021 | Awards & Recognition
Vesalius is 1 of 4 life sciences startups to watch according to Sean Azarshahi, a VP with RBC who is very active in the life sciences space. You can find the Vancouver Tech Journal article...
Recent Comments